Skip to main content
Erschienen in: Journal of Clinical Immunology 4/2023

11.01.2023 | Original Article

Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical, Immunological, and Genetic Features of 22 Patients from 15 Moroccan Kindreds

verfasst von: Abderrahmane Errami, Jamila El Baghdadi, Fatima Ailal, Ibtihal Benhsaien, Jalila El Bakkouri, Leila Jeddane, Noureddine Rada, Noufissa Benajiba, Khaoula Mokhantar, Kaoutar Ouazahrou, Sanae Zaidi, Laurent Abel, Jean-Laurent Casanova, Stéphanie Boisson-Dupuis, Jacinta Bustamante, Ahmed Aziz Bousfiha

Erschienen in: Journal of Clinical Immunology | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The first molecular evidence of a monogenic predisposition to mycobacteria came from the study of Mendelian susceptibility to mycobacterial disease (MSMD). We aimed to study this Mendelian susceptibility to mycobacterial diseases in Moroccan kindreds through clinical, immunological, and genetic analysis.

Methods

Patients presented with clinical features of MSMD were recruited into this study. We used whole blood samples from patients and age-matched healthy controls. To measure IL-12 and IFN-γ production, samples were activated by BCG plus recombinant human IFN-γ or recombinant human IL-12. Immunological assessments and genetic analysis were also done for patients and their relatives.

Results

Our study involved 22 cases from 15 unrelated Moroccan kindreds. The average age at diagnosis is 4 years. Fourteen patients (64%) were born to consanguineous parents. All patients were vaccinated with the BCG vaccine, and twelve of them (55%) developed locoregional or disseminated BCG infections. The other symptomatic patients had severe tuberculosis and/or recurrent salmonellosis. Genetic mutations were identified on the following genes: IL12RB1 in 8 patients, STAT1 in 7 patients; SPPL2A, IFNGR1, and TYK2 in two patients each; and TBX21 in one patient, with different modes of inheritance. All identified mutations/variants altered production or response to IFN-γ or both.

Conclusion

Severe forms of tuberculosis and complications of BCG vaccination may imply a genetic predisposition present in the Moroccan population. In the presence of these infections, systematic genetic studies became necessary. BCG vaccination is contraindicated in MSMD patients and should be delayed in newborn siblings until the exclusion of a genetic predisposition to mycobacteria.
Literatur
2.
Zurück zum Zitat Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol. 2002;20:581–620.CrossRefPubMed Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol. 2002;20:581–620.CrossRefPubMed
3.
Zurück zum Zitat Bustamante J, et al. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-gamma immunity. Semin Immunol. 2014;26(6):454–70.CrossRefPubMedPubMedCentral Bustamante J, et al. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-gamma immunity. Semin Immunol. 2014;26(6):454–70.CrossRefPubMedPubMedCentral
5.
6.
Zurück zum Zitat Rosain J, et al. Mendelian susceptibility to mycobacterial disease: 2014–2018 update. Immunol Cell Biol. 2019;97(4):360–7.CrossRefPubMed Rosain J, et al. Mendelian susceptibility to mycobacterial disease: 2014–2018 update. Immunol Cell Biol. 2019;97(4):360–7.CrossRefPubMed
8.
10.
Zurück zum Zitat Martin-Fernandez M, et al. A partial form of inherited human USP18 deficiency underlies infection and inflammation. J Exp Med. 2022;219(4). Martin-Fernandez M, et al. A partial form of inherited human USP18 deficiency underlies infection and inflammation. J Exp Med. 2022;219(4).
11.
Zurück zum Zitat Alawbathani S, Westenberger A, Ordonez-Herrera N, Al-Hilali M, Al Hebby H, Alabbas F, et al. Biallelic ZNFX1 variants are associated with a spectrum of immuno-hematological abnormalities. Clin Genet. 2022;101(2):247–254. https://doi.org/10.1111/cge.14081. Alawbathani S, Westenberger A, Ordonez-Herrera N, Al-Hilali M, Al Hebby H, Alabbas F, et al. Biallelic ZNFX1 variants are associated with a spectrum of immuno-hematological abnormalities. Clin Genet. 2022;101(2):247–254. https://​doi.​org/​10.​1111/​cge.​14081.
12.
14.
Zurück zum Zitat Dupuis S, et al. Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion. Immunol Rev. 2000;178:129–37.CrossRefPubMed Dupuis S, et al. Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion. Immunol Rev. 2000;178:129–37.CrossRefPubMed
16.
Zurück zum Zitat de Beaucoudrey L, et al. Revisiting human IL-12Rbeta1 deficiency: a survey of 141 patients from 30 countries. Med (Baltimore). 2010;89(6):381–402.CrossRef de Beaucoudrey L, et al. Revisiting human IL-12Rbeta1 deficiency: a survey of 141 patients from 30 countries. Med (Baltimore). 2010;89(6):381–402.CrossRef
19.
Zurück zum Zitat Hesseling AC, et al. Bacille Calmette-Guérin vaccine—induced disease in HIV-infected and HIV-uninfected children. Clin Infect Dis. 2006;42(4):548–58.CrossRefPubMed Hesseling AC, et al. Bacille Calmette-Guérin vaccine—induced disease in HIV-infected and HIV-uninfected children. Clin Infect Dis. 2006;42(4):548–58.CrossRefPubMed
20.
Zurück zum Zitat Kourime M, et al. Bécégites de l’enfant : diagnostic, classification et exploration. Arch Pediatr. 2016;23(7):754–9.CrossRefPubMed Kourime M, et al. Bécégites de l’enfant : diagnostic, classification et exploration. Arch Pediatr. 2016;23(7):754–9.CrossRefPubMed
21.
Zurück zum Zitat Ouederni M, et al. Clinical features of Candidiasis in patients with inherited interleukin 12 receptor beta1 deficiency. Clin Infect Dis. 2014;58(2):204–13.CrossRefPubMed Ouederni M, et al. Clinical features of Candidiasis in patients with inherited interleukin 12 receptor beta1 deficiency. Clin Infect Dis. 2014;58(2):204–13.CrossRefPubMed
22.
Zurück zum Zitat Byun M, et al. Whole-exome sequencing-based discovery of STIM1 deficiency in a child with fatal classic Kaposi sarcoma. J Exp Med. 2010;207(11):2307–12.CrossRefPubMedPubMedCentral Byun M, et al. Whole-exome sequencing-based discovery of STIM1 deficiency in a child with fatal classic Kaposi sarcoma. J Exp Med. 2010;207(11):2307–12.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Bogunovic D, et al. Mycobacterial disease and impaired IFN-gamma immunity in humans with inherited ISG15 deficiency. Sci. 2012;337(6102):1684–8.CrossRef Bogunovic D, et al. Mycobacterial disease and impaired IFN-gamma immunity in humans with inherited ISG15 deficiency. Sci. 2012;337(6102):1684–8.CrossRef
24.
Zurück zum Zitat Feinberg J, et al. Bacillus Calmette Guerin triggers the IL-12/IFN-gamma axis by an IRAK-4- and NEMO-dependent, non-cognate interaction between monocytes, NK, and T lymphocytes. Eur J Immunol. 2004;34(11):3276–84.CrossRefPubMed Feinberg J, et al. Bacillus Calmette Guerin triggers the IL-12/IFN-gamma axis by an IRAK-4- and NEMO-dependent, non-cognate interaction between monocytes, NK, and T lymphocytes. Eur J Immunol. 2004;34(11):3276–84.CrossRefPubMed
28.
Zurück zum Zitat Kong XF, et al. Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency. Nat Immunol. 2018;19(9):973–85.CrossRefPubMedPubMedCentral Kong XF, et al. Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency. Nat Immunol. 2018;19(9):973–85.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Kagawa R, et al. Alanine-scanning mutagenesis of human signal transducer and activator of transcription 1 to estimate loss- or gain-of-function variants. J Allergy Clin Immunol. 2017;140(1):232–41.CrossRefPubMed Kagawa R, et al. Alanine-scanning mutagenesis of human signal transducer and activator of transcription 1 to estimate loss- or gain-of-function variants. J Allergy Clin Immunol. 2017;140(1):232–41.CrossRefPubMed
30.
Zurück zum Zitat Humblet-Baron S, et al. IFN-gamma and CD25 drive distinct pathologic features during hemophagocytic lymphohistiocytosis. J Allergy Clin Immunol. 2019;143(6):2215-2226 e7.CrossRefPubMed Humblet-Baron S, et al. IFN-gamma and CD25 drive distinct pathologic features during hemophagocytic lymphohistiocytosis. J Allergy Clin Immunol. 2019;143(6):2215-2226 e7.CrossRefPubMed
31.
32.
Zurück zum Zitat Jeddane L, et al. Primary immunodeficiency classification on smartphone. J Clin Immunol. 2017;37(1):1–2.CrossRefPubMed Jeddane L, et al. Primary immunodeficiency classification on smartphone. J Clin Immunol. 2017;37(1):1–2.CrossRefPubMed
33.
Zurück zum Zitat Al-Mousa H, Al-Saud B. Primary immunodeficiency diseases in highly consanguineous populations from Middle East and North Africa: epidemiology, diagnosis, and care. Front Immunol. 2017;8:678.CrossRefPubMedPubMedCentral Al-Mousa H, Al-Saud B. Primary immunodeficiency diseases in highly consanguineous populations from Middle East and North Africa: epidemiology, diagnosis, and care. Front Immunol. 2017;8:678.CrossRefPubMedPubMedCentral
35.
36.
Zurück zum Zitat Altare F, et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Sci. 1998;280(5368):1432–5.CrossRef Altare F, et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Sci. 1998;280(5368):1432–5.CrossRef
37.
Zurück zum Zitat Gokturk B, et al. Infectious diseases, autoimmunity and midline defect in a patient with a novel bi-allelic mutation in IL12RB1 gene. Turk J Pediatr. 2016;58(3):331–6.CrossRefPubMed Gokturk B, et al. Infectious diseases, autoimmunity and midline defect in a patient with a novel bi-allelic mutation in IL12RB1 gene. Turk J Pediatr. 2016;58(3):331–6.CrossRefPubMed
38.
Zurück zum Zitat Jindal AK, et al. Recurrent Salmonella typhi infection and autoimmunity in a young boy with complete IL-12 receptor beta1 deficiency. J Clin Immunol. 2019;39(4):358–62.CrossRefPubMed Jindal AK, et al. Recurrent Salmonella typhi infection and autoimmunity in a young boy with complete IL-12 receptor beta1 deficiency. J Clin Immunol. 2019;39(4):358–62.CrossRefPubMed
39.
Zurück zum Zitat Ling G, et al. IL-12 receptor 1beta deficiency with features of autoimmunity and photosensitivity. Autoimmun. 2016;49(3):143–6.CrossRef Ling G, et al. IL-12 receptor 1beta deficiency with features of autoimmunity and photosensitivity. Autoimmun. 2016;49(3):143–6.CrossRef
40.
Zurück zum Zitat Minegishi Y, et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immun. 2006;25(5):745–55.CrossRef Minegishi Y, et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immun. 2006;25(5):745–55.CrossRef
42.
Zurück zum Zitat Boisson-Dupuis S, et al. Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes. Curr Opin Immunol. 2012;24(4):364–78.CrossRefPubMedPubMedCentral Boisson-Dupuis S, et al. Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes. Curr Opin Immunol. 2012;24(4):364–78.CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Dupuis S, et al. Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat Genet. 2003;33(3):388–91.CrossRefPubMed Dupuis S, et al. Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat Genet. 2003;33(3):388–91.CrossRefPubMed
44.
Zurück zum Zitat Vairo D, et al. Severe impairment of IFN-gamma and IFN-alpha responses in cells of a patient with a novel STAT1 splicing mutation. Blood. 2011;118(7):1806–17.CrossRefPubMed Vairo D, et al. Severe impairment of IFN-gamma and IFN-alpha responses in cells of a patient with a novel STAT1 splicing mutation. Blood. 2011;118(7):1806–17.CrossRefPubMed
45.
Zurück zum Zitat Dupuis S, et al. Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Sci. 2001;293(5528):300–3.CrossRef Dupuis S, et al. Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Sci. 2001;293(5528):300–3.CrossRef
46.
Zurück zum Zitat Dorman SE, et al. Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. Lancet. 2004;364(9451):2113–21.CrossRefPubMed Dorman SE, et al. Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. Lancet. 2004;364(9451):2113–21.CrossRefPubMed
47.
Zurück zum Zitat El Baghdadi J, El Azbaoui S, Ailal F, Akhaddar A, Sabri A, Kong X-F, et al. Human Genetics of Tuberculosis of the Nervous System. In: Turgut M, Akhaddar A, Turgut AT, Garg RK, editors. Tuberculosis of the Central Nervous System: Pathogenesis, Imaging, and Management. Cham: Springer Int Publ. 2017;11–22. https://doi.org/10.1007/978-3-319-50712-5_2. El Baghdadi J, El Azbaoui S, Ailal F, Akhaddar A, Sabri A, Kong X-F, et al. Human Genetics of Tuberculosis of the Nervous System. In: Turgut M, Akhaddar A, Turgut AT, Garg RK, editors. Tuberculosis of the Central Nervous System: Pathogenesis, Imaging, and Management. Cham: Springer Int Publ. 2017;11–22. https://​doi.​org/​10.​1007/​978-3-319-50712-5_​2.
48.
Zurück zum Zitat Hirata O, et al. Heterozygosity for the Y701C STAT1 mutation in a multiplex kindred with multifocal osteomyelitis. Haematol. 2013;98(10):1641–9.CrossRef Hirata O, et al. Heterozygosity for the Y701C STAT1 mutation in a multiplex kindred with multifocal osteomyelitis. Haematol. 2013;98(10):1641–9.CrossRef
49.
Zurück zum Zitat Roesler J, et al. Hematopoietic stem cell transplantation for complete IFN-gamma receptor 1 deficiency: a multi-institutional survey. J Pediatr. 2004;145(6):806–12.CrossRefPubMed Roesler J, et al. Hematopoietic stem cell transplantation for complete IFN-gamma receptor 1 deficiency: a multi-institutional survey. J Pediatr. 2004;145(6):806–12.CrossRefPubMed
50.
Zurück zum Zitat Schneppenheim J, et al. The intramembrane protease SPPL2a promotes B cell development and controls endosomal traffic by cleavage of the invariant chain. J Exp Med. 2013;210(1):41–58.CrossRefPubMedPubMedCentral Schneppenheim J, et al. The intramembrane protease SPPL2a promotes B cell development and controls endosomal traffic by cleavage of the invariant chain. J Exp Med. 2013;210(1):41–58.CrossRefPubMedPubMedCentral
51.
Zurück zum Zitat Ailal F, et al. Purulent pericarditis and colonic infiltrating to Salmonella enteritidis complicated by acute intussusception in a case of IL-12Rbeta1 deficiency. Arch Pediatr. 2014;21(12):1348–52.CrossRefPubMed Ailal F, et al. Purulent pericarditis and colonic infiltrating to Salmonella enteritidis complicated by acute intussusception in a case of IL-12Rbeta1 deficiency. Arch Pediatr. 2014;21(12):1348–52.CrossRefPubMed
52.
Zurück zum Zitat Boisson-Dupuis S, et al. IL-12Rbeta1 deficiency in two of fifty children with severe tuberculosis from Iran, Morocco, and Turkey. PLoS One. 2011;6(4): e18524.CrossRefPubMedPubMedCentral Boisson-Dupuis S, et al. IL-12Rbeta1 deficiency in two of fifty children with severe tuberculosis from Iran, Morocco, and Turkey. PLoS One. 2011;6(4): e18524.CrossRefPubMedPubMedCentral
Metadaten
Titel
Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical, Immunological, and Genetic Features of 22 Patients from 15 Moroccan Kindreds
verfasst von
Abderrahmane Errami
Jamila El Baghdadi
Fatima Ailal
Ibtihal Benhsaien
Jalila El Bakkouri
Leila Jeddane
Noureddine Rada
Noufissa Benajiba
Khaoula Mokhantar
Kaoutar Ouazahrou
Sanae Zaidi
Laurent Abel
Jean-Laurent Casanova
Stéphanie Boisson-Dupuis
Jacinta Bustamante
Ahmed Aziz Bousfiha
Publikationsdatum
11.01.2023
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 4/2023
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-022-01419-x

Weitere Artikel der Ausgabe 4/2023

Journal of Clinical Immunology 4/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.